Variables | Total (N = 101) | No HA (N = 77) | HA (N = 24) | P |
---|---|---|---|---|
Sex | ||||
Male | 72 (71.3%) | 58 (75.3%) | 14 (58.3%) | 0.108 |
Female | 29 (28.7%) | 19 (24.7%) | 10 (41.7%) | |
Age (years) | 62.45±12.79 | 63.38±13.37 | 59.46±10.41 | 0.192 |
BMI (kg/m2) | 25.60±5.34 | 25.84±3.83 | 26.73±3.24 | 0.142 |
Education | ||||
≥high school | 56 (55.4%) | 40 (51.9%) | 16 (66.7%) | 0.205 |
<high school | 45 (44.6%) | 37 (48.1%) | 8 (33.3%) | |
History of allergy | 13 (12.9%) | 8 (10.4%) | 5 (20.8%) | 0.292 |
Current smoking status | 43 (42.6%) | 34 (44.2%) | 9 (37.5%) | 0.565 |
Current alcohol use | 37 (36.6%) | 31 (40.3%) | 6 (25.0%) | 0.175 |
History of headache | 12 (11.9%) | 5 (6.5%) | 7 (29.2%) | 0.007 |
Hypertension | 59 (58.4%) | 46 (59.7%) | 13 (54.2%) | 0.629 |
Diabetes | 27 (26.7%) | 19 (24.7%) | 8 (33.3%) | 0.403 |
History of cerebral infarction | 8 (7.9%) | 6 (7.8%) | 2 (8.3%) | 1.000 |
Hyperlipaemia | 24 (23.8%) | 15 (19.5%) | 9 (37.5%) | 0.070 |
History of intervention | 44 (43.6%) | 35 (45.5%) | 9 (37.5%) | 0.493 |
Pathway | ||||
transradial | 90 (89.1%) | 66 (85.7%) | 24 (100%) | 0.062 |
transfemoral | 11 (10.9%) | 11 (14.3%) | 0 | |
Contrast media | ||||
Iodixanol | 54 (53.5%) | 38 (49.4%) | 16 (66.7%) | 0.138 |
Ultravist | 47 (46.5%) | 39 (50.6%) | 8 (33.3%) | |
Contrast media volume (ml) | ||||
Iodixanol | 152.78±92.42 | 167.37±92.87 | 118.13±84.16 | 0.055 |
Ultravist | 167.23±98.61 | 173.59±103.50 | 136.25±66.53 | 0.495 |
Exposure time in X-ray (min) | 19.42±13.39 | 20.40±13.90 | 16.26±11.32 | 0.050 |
Indication | ||||
angina | 58 (57.4%) | 43 (55.8%) | 15 (62.5%) | 0.804 |
AMI | 27 (26.7%) | 22 (28.6%) | 5 (20.8%) | |
Others | 16 (15.8%) | 12 (15.6%) | 4 (16.7%) | |
Intervention | ||||
CAG | 28 (27.7%) | 20 (26.0%) | 8 (33.3%) | 0.482 |
PCI | 73 (72.3%) | 57 (74.0%) | 16 (66.7%) |